NATCO Pharma included as defendant in antitrust lawsuit in the US

NATCO Pharma Limited would like to update that Celgene Corporation, Bristol Myers Squibb, Breckenridge Pharmaceutical Inc. and Natco Pharma Ltd. have been named defendants along with others in an antitrust lawsuit in the US by Louisiana Health Service & Indemnity Company D/B/A Blue Cross and Blue Shield of Losisiana and HMO Louisiana Inc., regarding Pomalidomide (POMALYST). Natco believes this matter is without merit. Breckenridge is the ANDA holder and distribution partner for the generic product in the US.

Strides Pharma Science to acquire 100% in Strides Pharma Services

Strides Pharma Science Limited to acquire 100% in Strides Pharma Services Pvt Ltd. As part of internal restructuring within the group, Board of Directors of Strides Pharma Science Limited at their meeting held today i.e., September 7, 2023, have approved acquisition of 100% shareholding in Strides Pharma Services Private Limited (SPSPL). SPSPL is currently a wholly owned subsidiary (WOS) of Arco Lab Private Limited, a WOS of the Company. Post the said acquisition, SPSPL shall be a direct WOS of the company. SPSPL was set up to provide business support services for pharmaceutical and biopharmaceutical sector, within India and across the world.

Aurobindo Pharma updates on US FDA inspection at Unit 3

The United States Food and Drug Administration (US FDA) inspected the Company's Unit III, a Formulation manufacturing facility situated at Bachupally Village, Medchal Malkajgiri District, Telangana, from July 14 to July 21, 2023. The Unit has now received an Establishment Inspection Report classifying the facility as "Voluntary Action Indicated" (VAI).